Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting.
Times cited: 13
Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress Responses.
Times cited: 2
Novel immunotherapies in lymphoid malignancies.
Nature reviews. Clinical oncology.
Times cited: 36